Phase 1b, Open-label Study of Tune-401 to Assess Safety, PK and PD in Adults With Chronic Hepatitis B

Phase 1 Recruiting 36 enrolled Tune Therapeutics, Inc.

Non-randomizedSequentialOpen-labelTreatment

Summary

This study will be conducted to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of Tune-401 in adult participants with Chronic Hepatitis B.

Timeline

Start: 2024-11-29
Primary completion: 2028-06-28
Completion: 2028-10-30

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Tune-401	Unknown	—	Intravenous

Phase 1b, Open-label Study of Tune-401 to Assess Safety, PK and PD in Adults With Chronic Hepatitis B

Summary

Timeline

Drugs

Indications